Leadership Team

The Leadership Team at BerGenBio is responsible for setting strategic direction and overseeing the organization's operations to advance the development of first-in-class AXL inhibitors. Comprising the CEO, CFO, and Chief Business Officers, the team focuses on driving business growth, ensuring financial sustainability, and fostering partnerships to bring innovative treatments for aggressive, treatment-resistant cancers to market. Their leadership is crucial in aligning scientific and commercial objectives to achieve the company's mission.